Hill-Rom VersaLet infant warmer/incubator 510(k) pending at FDA.
This article was originally published in The Gray Sheet
Executive Summary
HILL-ROM VERSALET INFANT WARMER/INCUBATOR LAUNCH is planned in the first half of 1998 pending 510(k) clearance of the product, the company says. The device, which combines the features of a radiant warmer with the those of an incubator, "eliminates transfers from infant warmers to incubators and back again, thus relieving a significant amount of physiological stress on the infant," the firm maintains. The Versalet, for which a 510(k) is under review at FDA, is intended for newborn care in the neonatal intensive care unit.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.